Literature DB >> 12359776

Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond.

Francisco Lo Coco1, Arthur Zelent, Adi Kimchi, Michael Carducci, Steve D Gore, Samuel Waxman.   

Abstract

The Joint International Conference on Acute Promyelocytic Leukemia and Differentiation Therapy held from October 4-7, 2001 in Rome, Italy was part of a series of biannual conferences, which had its beginnings in Sardinia in 1985, with the goal of establishing differentiation induction and programmed cell death as cancer cell-selective therapies. As in the past, the organizers of this meeting joined basic and clinical investigators in workshops to establish collaboration and information exchange. Because only a portion of the conference is summarized, additional information can be obtained from the abstracts published in Journal of Biological Regulators and Homeostatic Agents, Volume 15, 2001. The next International Conference on Differentiation Therapy will be held in Shanghai from October 24-27, 2003.

Entities:  

Mesh:

Year:  2002        PMID: 12359776

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies.

Authors:  Kang-Yu Lin; Xing-Ju Zhang; Dan-Dan Feng; Hua Zhang; Cheng-Wu Zeng; Bo-Wei Han; Ai-Dong Zhou; Liang-Hu Qu; Ling Xu; Yue-Qin Chen
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

2.  Effects of tachyplesin on the regulation of cell cycle in human hepatocarcinoma SMMC-7721 cells.

Authors:  Qi-Fu Li; Gao-Liang Ou-Yang; Xuan-Xian Peng; Shui-Gen Hong
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 3.  Linking the epigenetic 'language' of covalent histone modifications to cancer.

Authors:  S B Hake; A Xiao; C D Allis
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

Review 4.  The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia.

Authors:  Xiao-Shuang Wang; Jun-Wu Zhang
Journal:  J Cell Mol Med       Date:  2008-06-28       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.